INS and type 2 diabetes mellitus: Inhibition of muscle insulin signaling and insulin resistance inhibits insulin action on adipose glucose uptake and lipid synthesis, further increasing the rate of FFA release into the circulation, and contributes to the development of insulin resistance and type 2 diabetes [15].